Not Signed In - PTC Therapeutics Announces Positive Phase 2 Results For PTC124 In Cystic Fibrosis
Sat, 04 Nov 2006 08:00 AM EST
... PTC Therapeutics, Inc. (PTC), a biopharmaceutical company focused on the discovery and development of small-molecule drugs targeting post-transcriptional control processes, today announced the findings from two Phase 2 clinical trials of PTC124 in patients with cystic fibrosis (CF) due to a nonsense mutation. [click link for full article] ...
Related Topics
- Cystic Fibrosis
- Pulmonary Fibrosis
- Cystic Hygroma
- Pharmacology
- Food Recommendations: South Beach Diet - Phase 2
- Food Recommendations: South Beach Diet - Phase 1
- Tb
- Mastitis
- Brain injury that results in physical, emotional, or intellectual changes or deficits
- Cystic changes in the brain
- Fibrosis
- Medullary cystic kidney disease
- Retroperitoneal fibrosis
- Hepatic Fibrosis
- Interstitial pulmonary fibrosis
- Lung scarring (fibrosis)
- Idiopathic pulmonary fibrosis
- Prenatal Testing
- Progressive massive fibrosis (scarring)
- Deformity of the arm, shoulder contracture or fibrosis (frozen shoulder)
email this page
print this page
bookmark this page
feedback on this page
